Shanghai Pharmaceuticals Holding Co., Ltd (FRA:S1R)

FRA:S1R Revenue

Shanghai Pharmaceuticals Holding had revenue of 73.48B CNY in the quarter ending September 30, 2025, with 4.65% growth. This brings the company's revenue in the last twelve months to 280.69B, up 3.04% year-over-year. In the year 2024, Shanghai Pharmaceuticals Holding had annual revenue of 275.25B with 5.75% growth.

• Revenue (ttm): 280.69B CNY
• Revenue Growth: +3.04%
• P/S Ratio: 0.22
• Revenue / Employee: 5.68M CNY
• Employees: 49,402
• Market Cap: 7.29B EUR

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	275.25B	14.96B	5.75%
Dec 31, 2023	260.30B	28.31B	12.21%
Dec 31, 2022	231.98B	16.16B	7.49%
Dec 31, 2021	215.82B	23.92B	12.46%
Dec 31, 2020	191.91B	5.34B	2.86%